Home4DX • ASX
4DMedical Ltd
$0.63
Sep 27, 7:00:00 PM GMT+10 · AUD · ASX · Disclaimer
StockAU listed security
Previous close
$0.45
Day range
$0.53 - $0.67
Year range
$0.41 - $1.10
Market cap
255.76M AUD
Avg Volume
334.14K
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Financials
Income Statement
Revenue
Net income
(AUD)Jun 2024Y/Y change
Revenue
1.48M1,172.70%
Operating expense
12.56M11.42%
Net income
-10.19M-33.78%
Net profit margin
-687.8489.49%
Earnings per share
——
EBITDA
-11.09M-5.51%
Effective tax rate
-0.01%—
Total assets
Total liabilities
(AUD)Jun 2024Y/Y change
Cash and short-term investments
30.61M-56.01%
Total assets
120.02M29.16%
Total liabilities
49.09M128.71%
Total equity
70.93M—
Shares outstanding
410.39M—
Price to book
2.62—
Return on assets
-23.28%—
Return on capital
-36.73%—
Net change in cash
(AUD)Jun 2024Y/Y change
Net income
-10.19M-33.78%
Cash from operations
-8.06M8.54%
Cash from investing
-339.48K-21.29%
Cash from financing
-233.98K-101.11%
Net change in cash
-8.64M-172.48%
Free cash flow
-5.43M13.25%
About
4DMedical is a medical technology company, based in Australia and the United States. 4DMedical created X-ray Velocimetry Lung Ventilation Analysis Software based on the company's proprietary XV Technology. XV Technology uses patented algorithms adapted from advanced aerodynamics research to process and enhance X-ray and Computed Tomography images. Airflow is measured throughout all regions of the lung, across all phases of the breath—providing clinicians with quantitative lung ventilation data in a report. 4DMedical has commercialized its XV Technology via a Software as a Service model, where patients are scanned using existing imaging equipment and analyzed by 4DMedical remotely. Airflow is measured throughout all regions of the lung, across all phases of the breath, delivering the capability to quantify regional lung function throughout the respiratory cycle, at every location within the lung. The lung function data is provided to clinicians and patients in a report that includes color-coded lung images. This approach enables the detection of subtle functional losses before lung structure is irreversibly effected by the disease. Wikipedia
Founded
2013
Employees
131
Search
Clear search
Close search
Google apps
Main menu